AVEO Oncology logo

AVEO Oncology

Committed to delivering medicines that provide a better life for patients with cancer.

197 employees · est. 2001 · Boston, United States

VS
NextCure, Inc. logo

NextCure, Inc.

49 employees · est. 2015 · Beltsville, United States

AVEO Oncology is the older company (2001 vs 2015); AVEO Oncology is the larger of the two.

Side-by-Side Comparison

AVEO Oncology NextCure, Inc.
Founded
2001 older 2015
Headquarters
Boston, United States Beltsville, United States
Employees
197 larger 49
Industry
Biotechnology, Health Care, Health and Wellness Biopharma, Biotechnology, Health Care
Funding Stage
Post Ipo Equity Post Ipo Equity
Total Funding
Not tracked yet $310.00M
Funding Rounds
14 4
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Oncology-focused Biopharmaceutical, Cancer Therapeutics, Drug Development, Clinical Development, Immuno-oncology Combinations, Proprietary Cancer Biology Platform, Targeted Cancer Therapies, Biopharmaceutical Company, Diversity And Inclusion, Late-stage Biopharmaceutical, Commercial-stage, Integrated Cancer Biology, Novel Cancer Therapies, Collaborations With Pharmaceutical Companies Biopharmaceutical, Immunomedicines, Immunotherapy, Immuno-Oncology, Cancer Treatment, Biological Pathways, Immunotherapy Products, Drug Development, Clinical-Stage, Cancer Research, Immune System, Therapeutic Targets, Functional Impact, FIND-IO Platform
Website
aveooncology.com nextcure.com
AVEO Oncology logo

About AVEO Oncology

AVEO Oncology is a commercial-stage, oncology-focused biopharmaceutical company established in 2001. The company's slogan, "Committed to delivering medicines that provide a better life for patients with cancer," reflects its dedication to improving the lives of cancer patients. AVEO currently market...

NextCure, Inc. logo

About NextCure, Inc.

NextCure, Inc. is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in the United States. The company is dedicated to discovering and developing novel, first-in-class immunomedicines aimed at treating cancer and other immune-related diseases by restoring normal immune func...

We will tell you when either one moves

BounceWatch watches AVEO Oncology and NextCure, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at AVEO Oncology and NextCure, Inc. — by email.

Frequently Asked Questions

AVEO Oncology — Committed to delivering medicines that provide a better life for patients with cancer.. NextCure, Inc.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
AVEO Oncology has raised undisclosed funding while NextCure, Inc. has raised $310.00M.
AVEO Oncology and NextCure, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare AVEO Oncology with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AVEO Oncology on 11 Nov 2024, and NextCure, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy